等待開盤 09-20 09:30:00 美东时间
0.000
0.00%
Natera press release (NASDAQ:NTRA): Q2 GAAP EPS of -$0.30 beats by $0.40. Revenue of $413.3M (+58.1% Y/Y) beats by $70.84M. More on Natera Natera: Overdue For A Breather Injunction against NeoGenomics...
08-09 04:29
业绩表现亮眼,助推多只标的股价飙升!康沃系统绩后涨22.8%,NeoGenomics涨18%,海德思哲涨15.2%>>
07-31 17:58
An injunction that blocked NeoGenomics (NASDAQ:NEO) from selling its cancer test, the RaDaR assay, was affirmed by an appeals court. A federal court in North Carolina has issued a preliminary injuncti...
07-12 23:24
David Iben put it well when he said, 'Volatility is not a risk we care about. W...
06-20 20:34
专题:聚焦美股2024年第一季度财报 Dell最新一季的业绩显示,存储业务与上一季度持平,营业利润不增反降。 本文作...
05-31 20:18
NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology
05-28 20:10
The Q1 earnings report for NeoGenomics (NASDAQ:NEO) was released on Tuesday, Ap...
05-10 19:21
Benchmark analyst Bruce Jackson reiterates NeoGenomics (NASDAQ:NEO) with a Buy and maintains $18 price target.
05-01 23:19
Ratings for NeoGenomics (NASDAQ:NEO) were provided by 4 analysts in the past th...
05-01 02:00
Needham:维持NeoGenomics(NEO.US)评级,由买入调整至买入评级, 目标价由24.00美元调整至19.00美元。
05-01 01:22